Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase II trial of combination therapy with continuous-infusion PALA and bolus-injection 5-FU.

Phase II trial of combination therapy with continuous-infusion PALA and bolus-injection 5-FU. Cancer Treat Rep. 1982 Feb; 66(2):299-303.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.